ESR1 and breast cancer: In addition, in a subset of the breast cancer cell lines, CD146 expression suppressed ER expression and overexpression of CD146 in breast cancer cells induced Akt (also known as protein kinase B) activity, which is recognized as one of the mechanisms contributing to endocrine resistance [2,12,21,22].